Toxicological profile of a low molecular weight spleen peptide formulation used in supportive cancer therapy

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 9, 1997, Pages 1047-1051

  Hartleb, Martin ^a   Leuschner, Jost ^b  

^a HorFerVit Pharma GmbH   (Germany)

^b LPT Lab of Pharmacol and Toxicol   (Germany)

Author keywords

GP 1; Low molecular weight spleen peptide formulation; Oligopeptides; Polyerga , toxicity studies

Indexed keywords

CYTOKINE; OLIGOPEPTIDE; POLYERGA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ACTIVITY; DRUG SAFETY; EMBRYOTOXICITY; FEMALE; GUINEA PIG; IMMUNOTOXICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LD 50; MALE; MOUSE; MUTAGENICITY; NONHUMAN; PHARMACODYNAMICS; RAT; REPRODUCTIVE TOXICITY; TOXICITY TESTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BEHAVIOR, ANIMAL; CARDIOVASCULAR DISEASES; CONVULSANTS; DOGS; DRUG COMBINATIONS; FEMALE; GASTROINTESTINAL DISEASES; GLYCOPEPTIDES; GUINEA PIGS; HUMANS; MICE; MICE, INBRED STRAINS; MUTAGENICITY TESTS; PAIN; PHENOLS; PREGNANCY; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SWINE; TERATOGENS;

EID: 0030766302     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Berressem, P., Frech, S., Hartleb, M., Tumordiagn. Ther. 16, 45 (1995)
2. Hartleb, M., Skiba, G., Görtelmeyer, R., Naturamed 9, 22/430 (1993)
3. Borghardt, J. E., Rosien, B., Frech, S. et al., Support. Care Cancer 3, 360 (1995)
4. De Ojeda, G., Diez-Orejas, R., Protolés, P. et al., Res. Exp. Med. 194, 261 (1994)
5. Baier, J. E., Neumann, H. A., Taufighi-Chirazi, T. et al., Tumordiagn. Ther. 15, 21 (1993)
6. Jurin, M., Zarkovic, N., Borovic, S., Period. Biol. 97, 69 (1995)
7. Jurin, M., Zarkovic, N., Zoran, I. et al., Clin. Exp. Metastasis 15, 55 (1996)
8. Van't Veen, A., de Ruyter, H., Mouton, J. W. et al., Forsch. Komplementärmed. 3, 218 (1996)
9. Irwin, S., Gordon Res. Conf. on Medical Chem. 133 (1959)
10. Chen, G., Portman, R., in: R. A. Turner (ed.), Screening Methods in Pharmacology, pp. 79, Academic Press, New York-London (1965)
11. Witkin et al., in: R. A. Turner (ed.), Screening Methods in Pharmacology, pp. 92, Academic Press, New York-London (1965)
12. Kuhn, W. L., van Maanen, E. F., in: R. A. Turner (ed.), Screening Methods in Pharmacology, pp. 78, Academic Press, New York-London (1965)
13. Magnus, R., Pflüger's Arch. 102, 123 (1904)
14. Timmermann, H., Scheffler, N. G., J. Pharm. Pharmacol. 20, 78 (1968)
15. Janssen, P. A. J., Jageneau, A., in: R. A. Turner (ed.), Screening Methods in Pharmacology, pp. 142, Academic Press, New York-London (1965)
16. Colquhoun, D. (ed.), Lectures on Biostatistics, Clarendon Press, Oxford (1971)
17. Dawson, A. A., Stain Technol. 1, 123 (1926)
18. Wilson, J. G., in: J. G. Wilson, J. Warkany (eds.), Teratology: Principles and Techniques, pp. 251-277, University of Chicago Press, Chicago (1965)
19. Bartlett, M. S., Proc. Roy. Soc. A 160, 268 (1937)
20. Dunnett, C. W., J. Am. Statist. Assoc. 50, 1096 (1955)
21. Fisher, R. A., in: E. Weber (ed.), Grundlagen der biologischen Statistik, 6th ed., Gustav Fischer Verlag, Stuttgart (1967)
22. Magnusson, B., Kligman, A. M., J. Invest. Dermatol. 52, 268 (1969)